{"id":"W3040840440","doi":"10.1056/nejmoa2003715","title":"Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS","year":2020,"lang":"de","type":"article","venue":"New England Journal of Medicine","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":543,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Montreal Neurological Institute and Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Placebo; SOD1; Amyotrophic lateral sclerosis; Adverse effect; Randomization; Internal medicine; Confidence interval; Cerebrospinal fluid; Pharmacokinetics; Clinical endpoint; Hazard ratio; Anesthesia; Gastroenterology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001306184,0.002335639,0.001906299,0.0004219378,0.0004116154,0.0008226305,0.000744408,0.001857528,0.00773395],"category_scores_gemma":[0.0009469665,0.0007288199,0.001223245,0.0001954673,0.000674482,0.0008041855,0.0003143079,0.002270232,0.001149238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008246468,"about_ca_system_score_gemma":0.001142409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008537592,"about_ca_topic_score_gemma":0.002528761,"domain_scores_codex":[0.999669,0.0001289197,0.00001900941,0.000081573,0.00003347149,0.00006803367],"domain_scores_gemma":[0.9995222,0.00009467229,0.0001374036,0.0000336343,0.00005537062,0.0001566548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9118255,0.02330057,0.0008231252,0.0009064132,0.0009186864,0.0001010676,0.00009159758,0.000633024,0.02845285,0.0002105696,0.003752402,0.02898415],"study_design_scores_gemma":[0.8374702,0.1563547,0.001745,0.00004424379,0.0002910983,0.00008561942,0.0000213477,0.0004006982,0.001835936,0.00017053,0.001563089,0.00001743929],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777185,0.003827385,0.00162021,0.001259219,0.0007561302,0.008795653,0.002938744,0.0003451574,0.002739025],"genre_scores_gemma":[0.9671327,0.003121449,0.004194833,0.00258725,0.0005349174,0.01126563,0.003302603,0.00006640427,0.007794234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00773395,"threshold_uncertainty_score":0.02587259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0854671521943647,"score_gpt":0.3706397178702581,"score_spread":0.2851725656758934,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}